AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Lilly Is Selling Zepbound Vials at 50% Discount to Shots
Bloomberg Businessweek
Pharmaceutical Innovation in Weight Loss Drugs
15min Snip
00:00
Summary
Transcript
Episode notes
This chapter examines a pharmaceutical company's strategic decision to offer weight loss medications in vials at a discount, particularly focusing on Medicare patients. It highlights the innovative direct-to-consumer distribution model and the implications of cash payments outside traditional insurance coverage. The chapter also discusses the growing popularity of GLP-1 weight loss drugs and the evolving landscape of the pharmaceutical industry as companies shift to direct sales channels.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode